论文部分内容阅读
目的:对我院2002～2004年祛瘀剂中抗心绞痛中成药应用情况进行分析评估,为临床用药提供参考。方法:对3年中消耗的抗心绞痛中成药的用药金额、用药频度(DDDs)及日均费用的变化进行统计分析。结果:2002～2003年DDDs居前3位的药品是血塞通片、复方丹参片、复方丹参滴丸。2004年DDDs居前3位的药品是血塞通片、复方丹参滴丸、地奥心血康胶囊。受医疗制度改革的影响,2004年全年用药金额有较大幅度的下降。结论:DDDs居前3位的药品,日用药金额较低,说明患者最常用的都是价格不高、疗效可靠的药品。
Objective: To analyze and evaluate the application of Chinese patent medicine for anti-angina pectoris in our hospital from 2002 to 2004, and provide reference for clinical drug use. Methods: Statistical analysis was conducted on the changes in the amount, frequency of drug use (DDDs), and daily average cost of anti-angina pharmacotherapies consumed in 3 years. Results: The top 3 drugs for DDDs from 2002 to 2003 were Xuesaitong Tablets, Compound Danshen Tablets, and Compound Danshen Dripping Pills. The top three drugs for DDDs in 2004 were Xuesaitong Tablets, Compound Danshen Dripping Pills, and Di’ao Xinxuekang Capsules. Affected by the reform of the medical system, the amount of medication used in 2004 has dropped significantly. Conclusion: The top three drugs for DDDs have lower daily doses, indicating that the most commonly used drugs are those with low price and reliable efficacy.